InSCREENex GmbH

CI-huFIB

Immortalized Human Fibroblasts

CI-huFIB are immortalized human fibroblasts. Fibroblasts are the essential cells of the connective tissue, where they produce extracellular matrix, contribute to tissue repair and wound healing, and maintain tissue structure. Fibroblasts are often used together with epithelial cells in co-culture models to model tissue fibrosis.

CI-huFIBs are dermis-derived fibroblasts.

We also offer a serum-free cell culture system with our CI-huFIBs, which require Collagen-coating of cell culture vessels.

Characteristics

  • Spindle-like morphology
  • Responsive to TGFβ
  • Vimentin positive

Buying and Ordering the Cells

Academic Research

Non-profit academic and research institutions, universities, and governmental entities may purchase the cells for internal, non-commercial research under inscreenex’s Academic Research Limited Use Label License. This license is intended for internal research only.

Industry Research

Industry customers may purchase the cells for internal research and development under inscreenex’s Industry Research Limited Use Label License. This license is intended for internal R&D, drug discovery and assay development use only.

Commercial Use

Industry customers planning to use the cells for true commercial purposes require a separate Commercial Use license from inscreenex. This includes, for example, providing services to third parties, incorporating the cells into a product or platform, or using the cells in manufacturing, QC, or batch-/lot-release testing.

How to Order

To request a quote, please email us at  or use the contact form provided below.

We are already registered on several digital order processing platforms, if you would like to add us as a registered supplier, please contact us at  and we are happy to help.

Supplied as

Each license includes 1 vial of >0.5Mio viable cells. Additional or replacement vials can be purchased for a fee of 450€.

Catalog Number
INS-CI-1010
Features and Applications
  • Spindle-like morphology
  • TGFβ-responsive
  • Fibrosis research
Price Academic Research
900€
Price Industry Research
6200€
Product Sheet
Academic Research Limited Use Label License
Industry Research Limited Use Label License

Product Details

CI-huFIBs at low and high confluency, cultured in huFIB Medium (Cat.-No. INS-ME-1001) as a 2D monolayer.

Coming Soon!

Stay tuned for comprehensive details on our cell line characteristics and corresponding protocols, which will be available here shortly.

We recommend the following reagents for the cell culture of this cell line: 

Growth Medium: huFIB Medium (INS-ME-1001); Serum-free huFIB Medium (INS-ME-1018)

Coating: Collagen coating only required for serum-free culture (INS-SU-1017)

Freezing Medium: Cell Freezing Medium (INS-SU-1027)

Please note that while you may be able to adapt the cells to different cell culture reagents, we can only guarantee optimal performance using the recommended reagents.

  • Product Sheet including all relevant protocols and instructions (PDF)
  • Material Safety Data Sheet (PDF)
  • Request CoA (Email)

Coming Soon!

Stay tuned for comprehensive protocols for this cell line, from routine cell cultures to assay manuals.

Related Products

Medium kit for culture of immortalized fibroblasts.

  • Fibroblast cell culture
  • Medium kit
  • 500ml
More details
and prices 🠆

Serum-free medium kit for culture of immortalized fibroblasts.

  • Fibroblast culture, serum free
  • Medium kit
  • 500ml
More details
and prices 🠆

Coating Solution for culture of various immortalized cells.

  • Various cell types
  • Coating solution
  • 50, 100 or 300ml
More details
and prices 🠆

Medium for cryopreservation of immortalized and stable cells.

  • Cryopreservation Medium
  • Ready-to-use
  • 30ml
More details
and prices 🠆

Product FAQ

The fibroblast cell line is established from primary cells that were isolated from human foreskin dermal fibroblasts.

Yes, we have established a serum-free culture of CI-huFIB cells. Please note that serum-free culture requires coating of cell culture surfaces. Please refer to the Product Sheet for a detailed protocol.

For the best performance of this cell line, we advise using our Medium and Coating Solutions specified in the product sheet. These have been specially optimized for these cells. While it may be possible to adapt the cells to a different medium, we cannot assure their optimal performance outside our recommended Medium and Coating Solution. To validate any new culturing conditions, we suggest conducting comparative tests with our recommended protocols to confirm the cells’ expected behavior.

All our cell lines were immortalized using our custom library of immortalization genes. This library contains a combination of specifically selected immortalization genes encoded in lentiviruses. For a detailed description of our immortalization technology refer to Lipps et al. Nat comm vol. 9,1 994. 2018.

Firstly, it is worth mentioning that passage number is not always a reliable indicator of cell ageing due to its dependence on variables like seeding densities and split ratios. However, they can provide useful guidance in routine cell culture.

Our cell lines are truly immortalized, allowing for indefinite culturing. Nonetheless, we advise caution beyond passage 50. While more stable than typical cancer cell lines, our cells can still undergo changes with prolonged culture. We recommend periodically assessing cell performance after passage 50.

Typically, our immortalized cells are provided at passages 5 to 15. To avoid running out of material, we suggest banking cells immediately after initial expansion. This strategy ensures you always have sufficient cells for your research.

Should there be any concerns about depleting your cell stock, you have the option to order a new vial of cells as a replacement for a handling fee.

This cell line is BSL 1 according to German legislation. However, persons working with such cell lines and their employers are required to familiarize themselves with the national regulations and safety precautions, as they may differ. Our provided biosafety classification does not provide any exemption from this responsibility. 

Yes, industry customers planning to use the cells for true commercial purposes may request a separate Commercial Use license from inscreenex. This includes, for example, providing services to third parties, incorporating the cells into a product or platform, or using the cells in manufacturing, QC, or release workflows.

Please contact us at .

Industry customers planning to use the cells for internal R&D, drug discovery and assay development may purchase the cells under the inscreenex Industry Research Limited Use Label License.

Our immortalized cell lines are fully characterized and can be expanded indefinitely, making them a one-time purchase for perpetual use. This differs from primary cells, which are consumables you would need to repurchase. The licensing model not only respects the perpetual use value but also allows us to adjust fees based on your specific use case. Consider two scenarios: Customer A wants the cells for a single assay at one site for a limited time, while Customer B plans to use them globally across multiple sites for drug discovery and additionally transfer them to a CRO. Charging both customers the same one-time fee would not account for the vastly different use cases. That’s why our license fees are tailored to fit your unique needs.

Literature and Reference

Lipps, Christoph, et al. ‘Expansion of Functional Personalized Cells with Specific Transgene Combinations’. Nature Communications, vol. 9, no. 1, Mar. 2018, p. 994, https://doi.org10.1038/s41467-018-03408-4.

Yogeswaran, Athiththan, et al. ‘The C0-C1f Region of Cardiac Myosin Binding Protein-C Induces Pro-Inflammatory Responses in Fibroblasts via TLR4 Signaling’. Cells, vol. 10, no. 6, May 2021, https://doi.org10.3390/cells10061326.

Breitwieser, Kai, et al. ‘Detailed Characterization of Small Extracellular Vesicles from Different Cell Types Bazed on Tetraspanin Composition by ExoView R100 Platform’. International Journal of Molecular Sciences, vol. 23, no. 15, Aug. 2022, https://doi.org10.3390/ijms23158544.

We love to hear about your research! Please let us know if you have published using our cells.